June 8, 2026

Cerillion targets AI-led growth in telecoms software

Cerillion’s AI Hub strengthens its telecoms software platform with governed AI tools designed to improve automation, customer operations and commercial execution...

Unilever’s US innovation centre sharpens its beauty growth strategy

Unilever’s US$270 million New Haven innovation centre strengthens its focus on faster beauty, wellbeing and personal care product development...

Why biotech’s next phase is becoming more investable

Biotech investment interest is being supported by pharma patent pressures, renewed capital flows and breakthrough science creating new opportunities for scalable companies...

Structured products draw attention as investors look beyond cash

Investors are turning to structured products, defined outcome strategies and high-quality floating-rate credit as they look for clearer risk control and better ways to put cash to work...

Ethtry offers investors listed exposure to Ethereum treasury growth

Ethtry is positioning itself as a listed route into Ethereum treasury exposure, with formal custody, governance and reporting controls...

Verici Dx strengthens clinical case for kidney transplant risk testing

Verici Dx has strengthened the clinical evidence behind its pre-transplant kidney rejection risk test, supporting its investor case in precision transplant diagnostics...

iRhythm Holdings, Inc. (IRTC) Stock Analysis: Navigating a 65% Potential Upside in the Medical Devices Sector

iRhythm Holdings, Inc. (NASDAQ: IRTC) presents a compelling opportunity for investors within the healthcare sector, particularly in the niche of medical devices specializing in cardiac monitoring. With a market capitalization..

ADMA Biologics Inc (ADMA) Stock Analysis: Exploring a 110% Potential Upside in Biotech

ADMA Biologics Inc (NASDAQ: ADMA), a prominent player in the biotechnology sector, is capturing investor attention with its significant growth potential. With a market capitalization of $1.85 billion, this U.S.-based..

Krystal Biotech, Inc. (KRYS) Stock Analysis: Strong Buy Ratings and a Promising 7.24% Potential Upside

Krystal Biotech, Inc. (KRYS), a prominent player in the biotechnology sector, has captured the attention of investors with its innovative approach to genetic medicine. As a commercial-stage biotechnology company, Krystal..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: Exploring the Healthcare Biotech Leader’s Steady Trajectory

Soleno Therapeutics, Inc. (NASDAQ: SLNO), a key player in the biotechnology industry, has garnered significant attention from investors due to its strategic focus on developing treatments for rare diseases. With..

Waystar Holding Corp. (WAY) Stock Analysis: Exploring a 69% Potential Upside with Strong Buy Ratings

Waystar Holding Corp. (WAY), a key player in the healthcare sector, specifically within health information services, is garnering attention from investors for its remarkable potential upside of 69.13%. Headquartered in..

Vaxcyte, Inc. (PCVX) Stock Analysis: A Biotech with a Promising 130% Upside Potential

Vaxcyte, Inc. (NASDAQ: PCVX), a clinical-stage biotechnology company, is capturing significant attention from investors with its robust pipeline of innovative vaccines and a compelling 130.15% potential upside. Despite its current..

Grifols, S.A. (GRFS) Stock Analysis: Exploring a 42% Upside Potential in the Healthcare Sector

Grifols, S.A. (GRFS), a prominent player in the healthcare sector, stands at a crossroads with a compelling case for investors seeking exposure to the drug manufacturing industry. Specializing in plasma-derived..

Cytokinetics, Inc. (CYTK) Stock Analysis: A Promising Biotech Player with Potential 46.47% Upside

Cytokinetics, Incorporated (NASDAQ: CYTK), a key player in the biotechnology sector, is drawing significant attention from investors due to its innovative approach in the healthcare industry. With a market capitalization..

Moderna, Inc. (MRNA) Stock Analysis: Evaluating the Potential Amidst Volatility

Moderna, Inc. (NASDAQ: MRNA) remains a focal point in the biotechnology sector, renowned for its pioneering work in messenger RNA (mRNA) medicines. Headquartered in Cambridge, Massachusetts, Moderna has played a..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: Exploring a 59.95% Potential Upside in the Biotech Sector

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM), a pioneering entity in the biotechnology space, stands out with its innovative approach to tackling rare neuroendocrine diseases. The Boston-based company, with a market capitalization..

Integer Holdings Corporation (ITGR) Stock Analysis: A Medical Device Powerhouse with 6.06% Upside Potential

For investors keen on the healthcare sector, Integer Holdings Corporation (NYSE: ITGR) presents a compelling opportunity. As a dominant player in the medical devices industry, Integer’s expansive product lineup and..

Genmab A/S (GMAB) Stock Analysis: A 46% Upside Potential That Investors Can’t Ignore

Genmab A/S (NASDAQ: GMAB), a prominent player in the biotechnology sector, has captured investor interest with a compelling potential upside of 46.39%, according to the latest analyst ratings. Headquartered in..

Bausch + Lomb Corporation (BLCO): Investor Outlook and Potential 15.62% Upside in the Healthcare Sector

Bausch + Lomb Corporation (NYSE: BLCO), a venerable name in the healthcare sector, is capturing investor attention with a potential upside of 15.62%, as analysts project the stock to reach..

Labcorp Holdings Inc. (LH) Stock Analysis: A Diagnostic Powerhouse with 16.96% Potential Upside

Labcorp Holdings Inc. (NYSE: LH) is a formidable player in the healthcare sector, specifically in the Diagnostics & Research industry. With a market capitalization of $21.74 billion, Labcorp is a..

Search

Funds

June 8, 2026

Cerillion targets AI-led growth in telecoms software

Cerillion’s AI Hub strengthens its telecoms software platform with governed AI tools designed to improve automation, customer operations and commercial execution...

Unilever’s US innovation centre sharpens its beauty growth strategy

Unilever’s US$270 million New Haven innovation centre strengthens its focus on faster beauty, wellbeing and personal care product development...

Why biotech’s next phase is becoming more investable

Biotech investment interest is being supported by pharma patent pressures, renewed capital flows and breakthrough science creating new opportunities for scalable companies...

Structured products draw attention as investors look beyond cash

Investors are turning to structured products, defined outcome strategies and high-quality floating-rate credit as they look for clearer risk control and better ways to put cash to work...

Ethtry offers investors listed exposure to Ethereum treasury growth

Ethtry is positioning itself as a listed route into Ethereum treasury exposure, with formal custody, governance and reporting controls...

Verici Dx strengthens clinical case for kidney transplant risk testing

Verici Dx has strengthened the clinical evidence behind its pre-transplant kidney rejection risk test, supporting its investor case in precision transplant diagnostics...
Search

Funds

June 8, 2026

FTSE 100

Funds